SupplementDrug
Mitoquinone clinical trials
Also written MitoQ.
- studies test it
- 38
- open now
- 11
- in phase 3
- 1
- first study started
- 2006
Keep track of what changes. Save the mitoquinone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
38 studies that test it; most in 2022 (7)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 7 |
| 2025 | 3 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 4
- Phase 2
- 16
- Phase 3
- 1
- Phase 4
- 1
- No phase
- 18
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 35
Antipodean Pharmaceuticals, Inc. (3) · University of Edinburgh (2) · University of Colorado, Boulder (2) · VA Office of Research and Development (2) · Auburn University (2) · University of Nebraska (2) · Ball State University (2) · Virginia Commonwealth University (2)
Often tested with
Tested in the same studies.
Mitoquinol (3) · Mitoquinol mesylate (2) · Astaxanthine (1) · Protandim (1) · Melatonin (1) · Soybean oil, phospholipid emulsion (1) · Sapropterin (1) · Omega-N-Methylarginine (1)
Studies
Open first, then newest update. How each study uses mitoquinone is read from its arms, and is right about nine times in ten.
Testing it · 38
- : Vascular Function in Health and DiseaseRecruitingPhase 1D. Walter WrayNCT02966665Written as BQ-123, MitoQ, BH4
- Efficacy and Safety of MitoQ in Improving Cancer CachexiaNot yet recruitingPhase 2The First Affiliated Hospital of Xinxiang Medical CollegeNCT07836777Written as MitoQ (mitoquinol mesylate)
- The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older AdultsRecruitingPhase 2UConn HealthNCT06027554Written as Mitoquinone Mesylate
- Long-term COVID and RehabilitationRecruitingNot applicableVA Office of Research and DevelopmentNCT05373043Written as Mitoquinone
- Oral Antioxidant Therapy Targeted to the Mitochondria for Improving Brain Artery Health in Postmenopausal WomenNot yet recruitingNot applicableColorado State UniversityNCT07406243Written as Mitoquinone (MitoQ)
- Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life AdversityRecruitingNot applicableUniversity of IowaNCT07244809Written as Mitoquinone mesylate (MitoQ)
- Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 DiabetesNot yet recruitingNot applicableMedical College of WisconsinNCT07228208Written as MitoQ (mitoquinol mesylate)
- MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial DysfunctionRecruitingPhase 2/3Mclean HospitalNCT06191965Written as MitoQ
- WinQ : a Window of Opportunity Study With MitoQ in Breast CancerRecruitingNot applicableUniversité Catholique de LouvainNCT07142096Written as MitoQ (mitoquinol mesylate)
- Effects of an Antioxidant Supplement on Blood Vessel HealthRecruitingPhase 2University of GeorgiaNCT06424756Written as MitoQ
- The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular FunctionRecruitingNot applicableAuburn UniversityNCT04334135Written as MitoQ
- Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19CompletedPhase 2University of Texas Southwestern Medical CenterNCT05886816Written as Mitoquinone/mitoquinol mesylate
- Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell AnemiaCompletedNot applicableUniversity of PittsburghNCT04109820Written as MitoQ
- Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in HumansCompletedPhase 2University of Colorado, BoulderNCT04851288Written as MitoQ
- Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic SyndromeTerminatedPhase 2Iman Al-Naggar, PhDNCT06351683Written as MitoQ (mitoquinol mesylate)
- The Influence of Race and MitoQ Supplementation on Skin Blood Flow in the ColdCompletedNot applicableUnited States Army Research Institute of Environmental MedicineNCT06784531Written as Mitoquinone mesylate (MitoQ)
- MitoQ for Fatigue in Multiple Sclerosis (MS)CompletedPhase 1/2VA Office of Research and DevelopmentNCT04267926Written as 20 mg MitoQ
- MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative ColitisActive, not recruitingPhase 2University of EdinburghNCT04276740Written as MitoQ
- Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative ColitisWithdrawnPhase 2University of EdinburghNCT05539625Written as MitoQ
- An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral IllnessCompletedPhase 1/2University of California, Los AngelesNCT05381454Written as Mitoquinone/mitoquinol mesylate
Codes
What other systems call mitoquinone · ClinicalTrials.gg INT004352
- MeSH (NLM) C429014mitoquinoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 47BYS17IY0MITOQUINONE CATIONConfirmed NLM, Wikidata
- Wikidata Q27259044mitoquinone cationConfirmed NLM, Wikidata
- DrugBank DB05063One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C429014 | mitoquinone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 47BYS17IY0 | MITOQUINONE CATION | Confirmed NLM, Wikidata |
| Wikidata | Q27259044 | mitoquinone cation | Confirmed NLM, Wikidata |
| DrugBank | DB05063 | — | One source Wikidata |
Also registered as mitoquinone mesylate (UNII 6E01CG547T).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.